ClinicalTrials.Veeva

Menu

HEARS-SLP: Providing SLP-Delivered Hearing Health Care to Individuals With Cognitive Impairment

Johns Hopkins University logo

Johns Hopkins University

Status

Enrolling

Conditions

Cognitive Impairment
Hearing Loss
Dementia

Treatments

Device: HEARS-SLP device
Behavioral: HEARS-SLP program

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06008782
K23AG059900 (U.S. NIH Grant/Contract)
IRB00218068

Details and patient eligibility

About

Building upon the HEARS audiologist-community health worker (CHW) model, this study intervention will be delivered by a speech-language pathologist (SLP). The primary objective of the study is to develop and test an affordable and accessible hearing rehabilitative intervention that will be delivered by a SLP to individuals with cognitive impairment.

Enrollment

20 estimated patients

Sex

All

Ages

60 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 60 - 100 years old
  • English-speaking
  • Lives at home
  • Diagnosis of probable Alzheimer's Disease or other related dementia according to the core clinical criteria outlined in the National Institute on Aging (NIA) and Alzheimer's Association Guidelines
  • Availability of caregiver/study partner to participate in all study-related visits and who provides ≥8 hours of weekly oversight/care
  • Speech frequency pure tone average (0.5- 4 kHz) >25 db in the better-hearing ear; adult onset hearing loss
  • Stable (for 2 weeks or longer) dosing of medication (e.g. antidepressants, antipsychotics) for neuropsychiatric symptoms

Exclusion criteria

  • Current self-reported use of hearing aid or amplification device
  • Medical contraindication to use hearing aids ( e.g. draining ears)
  • Inability to participate in the 1-month follow up

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

20 participants in 2 patient groups, including a placebo group

Immediate treatment
Experimental group
Description:
immediate treatment
Treatment:
Behavioral: HEARS-SLP program
Device: HEARS-SLP device
Delayed treatment
Placebo Comparator group
Description:
1 month delayed treatment
Treatment:
Behavioral: HEARS-SLP program
Device: HEARS-SLP device

Trial contacts and locations

1

Loading...

Central trial contact

Carrie L Nieman, MD, MPH; Jami Trumbo, MSPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems